Azotemia clinical trials
The registry lists 25 studies for Azotemia across more than 10 countries. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2025-03-25.
Status
- Completed
- 16
- Status unknown
- 3
- Terminated
- 3
- Recruiting
- 2
- Withdrawn
- 1
Phase
- Phase 2
- 8
- Phase 3
- 5
- Phase 4
- 1
Where
- France
- 10
- United States
- 9
- Germany
- 8
- Canada
- 8
- Italy
- 7
- United Kingdom
- 7
Who runs them
Alexion Pharmaceuticals, Inc. (7) · Assistance Publique - Hôpitaux de Paris (2) · Mario Negri Institute for Pharmacological Research (1) · Hamilton Health Sciences Corporation (1) · University Hospital, Ghent (1) · AO GENERIUM (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Assiut University (1)
Studies
Recruiting first, then most recently updated. Showing 25 of 25 — search for more.
- Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic SyndromeRecruitingNCT05726916Phase 31 country
- National Registry of Rare Kidney DiseasesRecruitingNCT060658521 country
- Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring (EspacECU)CompletedNCT04859608Phase 31 country
- Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT03131219Phase 37 countries
- Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT02949128Phase 314 countries
- Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant RecipientsCompletedNCT03518203Phase 21 country
- A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUSCompletedNCT05569746Phase 21 country
- A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT017709518 countries
- Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney DiseaseCompletedNCT009304231 country
- Observational Study of Elizaria® in aHUS PatientsCompletedNCT047498101 country
- Azithromycin in Post Diarrheal Haemolytic and Uremic SyndromeCompletedNCT02336516Not applicable1 country
- Erythropoietin in Hemolytic Uremic SyndromeCompletedNCT03776851Phase 41 country
- Eculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated aHUS: A Case SeriesStatus unknownNCT035745061 country
- Outcame of Cases With Hemolytic Uremic Syndrome Attending Assiut University Child HospitalStatus unknownNCT03690024
- A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic SyndromeWithdrawnNCT03303313Phase 210 countries
- Complement Inhibition in aHUS Dialysis PatientsTerminatedNCT02464891Phase 21 country
- Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic SyndromeTerminatedNCT00004465Phase 32 countries
- An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic SyndromeCompletedNCT01194973Phase 27 countries
- aHUS Observational Long Term Follow-UpTerminatedNCT0152217012 countries
- Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT00838513Phase 27 countries
- An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic SyndromeCompletedNCT01193348Phase 29 countries
- Sensitivity and Specificity of NGAL in an Emergency Room PopulationCompletedNCT007867082 countries
- Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological AspectsCompletedNCT016665481 country
- Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4CompletedNCT014062881 country
- Rituximab in Patients With Relapsed or Refractory TTP-HUSStatus unknownNCT00531089Phase 21 country